← FDA Drug Approvals (Drugs@FDA)

LEVOCARNITINE SF

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2019-08-14

Drug application

FDA Application #

ANDA211676

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVOCARNITINE SF

Generic name

LEVOCARNITINE

Active ingredients

LEVOCARNITINE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

NOVITIUM PHARMA

Manufacturer

ANI Pharmaceuticals, Inc.

First approval

2019-08-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown